602 related articles for article (PubMed ID: 32321540)
1. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country.
Licciardi F; Giani T; Baldini L; Favalli EG; Caporali R; Cimaz R
Pediatr Rheumatol Online J; 2020 Apr; 18(1):35. PubMed ID: 32321540
[TBL] [Abstract][Full Text] [Related]
2. Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
Gheita TA; Salem MN; Eesa NN; Khalil NM; Gamal NM; Noor RA; Moshrif AH; Shereef RE; Ismail F; Noshy N; Fawzy RM; Elshebini E; Khalifa I; Saadany HE; Tharwat S; El-Najjar A; Fattah YA; Sallam R; El-Bahnasawy AS; Gharbia O; Hassan E; ElShanawany A; Mohamed EF; Senara S; Ismail M; Nasef SI; Abdalla AM; Elessawi D; Fawzy SM; Alfadl EA; Khalifa A; Abaza NM;
Rheumatol Int; 2020 Oct; 40(10):1599-1611. PubMed ID: 32710198
[TBL] [Abstract][Full Text] [Related]
3. How to manage rheumatic patients during the coronavirus pandemic.
Parisi S; Ditto MC; Finucci A; Fusaro E
Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511
[No Abstract] [Full Text] [Related]
4. Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology.
Saldarriaga Rivera LM; Fernández Ávila D; Bautista Molano W; Jaramillo Arroyave D; Bautista Ramírez AJ; Díaz Maldonado A; Hernán Izquierdo J; Jáuregui E; Latorre Muñoz MC; Restrepo JP; Segura Charry JS
Reumatol Clin (Engl Ed); 2020; 16(6):437-446. PubMed ID: 32800760
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.
Ceribelli A; Motta F; De Santis M; Ansari AA; Ridgway WM; Gershwin ME; Selmi C
J Autoimmun; 2020 May; 109():102442. PubMed ID: 32253068
[TBL] [Abstract][Full Text] [Related]
6. Rheumotologitsts' view on the use of hydroxychloroquine to treat COVID-19.
Sun X; Ni Y; Zhang M
Emerg Microbes Infect; 2020 Dec; 9(1):830-832. PubMed ID: 32338155
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: an unexpected indication for anti-rheumatic therapies?
Lucchino B; Di Franco M; Conti F
Rheumatology (Oxford); 2020 Jun; 59(6):1200-1203. PubMed ID: 32374874
[No Abstract] [Full Text] [Related]
8. Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.
Colafrancesco S; Scrivo R; Barbati C; Conti F; Priori R
Front Immunol; 2020; 11():1439. PubMed ID: 32655577
[TBL] [Abstract][Full Text] [Related]
9. Should coronavirus disease 2019 concern rheumatologists?
Kucharz EJ
Pol Arch Intern Med; 2020 Aug; 130(7-8):655-661. PubMed ID: 32426957
[TBL] [Abstract][Full Text] [Related]
10. Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
Misra DP; Agarwal V; Gasparyan AY; Zimba O
Clin Rheumatol; 2020 Jul; 39(7):2055-2062. PubMed ID: 32277367
[TBL] [Abstract][Full Text] [Related]
11. Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.
Coskun Benlidayi I; Kurtaran B; Tirasci E; Guzel R
Rheumatol Int; 2020 Oct; 40(10):1707-1716. PubMed ID: 32591970
[TBL] [Abstract][Full Text] [Related]
12. What is the role of rheumatologists in the era of COVID-19?
Marotto D; Sarzi-Puttini P
Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
[No Abstract] [Full Text] [Related]
13. Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon.
Haşlak F; Yıldız M; Adrovic A; Barut K; Kasapçopur Ö
Balkan Med J; 2020 Jun; 37(4):184-188. PubMed ID: 32264666
[TBL] [Abstract][Full Text] [Related]
14. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19.
Zhang X; Zhang Y; Qiao W; Zhang J; Qi Z
Int Immunopharmacol; 2020 Sep; 86():106749. PubMed ID: 32645632
[TBL] [Abstract][Full Text] [Related]
15. Managing rheumatic diseases during COVID-19.
Ladani AP; Loganathan M; Danve A
Clin Rheumatol; 2020 Nov; 39(11):3245-3254. PubMed ID: 32895747
[TBL] [Abstract][Full Text] [Related]
16. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
Yazdany J; Kim AHJ
Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
[TBL] [Abstract][Full Text] [Related]
17. [COVID-19: treatment strategies of German-speaking pediatric rheumatologists : Results of an online survey].
Janda A; Schuetz C; Heeg M; Minden K; Hedrich CM; Kallinich T; Hinze C; Schulz A; Speth F
Z Rheumatol; 2020 Sep; 79(7):710-717. PubMed ID: 32809050
[TBL] [Abstract][Full Text] [Related]
18. Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic.
Scuccimarri R; Sutton E; Fitzcharles MA
J Rheumatol; 2020 Jun; 47(6):783-786. PubMed ID: 32241801
[No Abstract] [Full Text] [Related]
19. COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments.
Ouédraogo DD; Tiendrébéogo WJS; Kaboré F; Ntsiba H
Clin Rheumatol; 2020 Jul; 39(7):2069-2075. PubMed ID: 32472461
[TBL] [Abstract][Full Text] [Related]
20. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
